Making
prescriptions
personal

About OneOme

OneOme, co-founded by Mayo Clinic, is working to deliver the most comprehensive, cost-effective pharmacogenomic testing and tools for all providers across the globe to use in everyday patient care. By increasing adoption of pharmacogenomics, OneOme may help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.

Awards

  • fast company logo
  • tekne logo
  • eureka logo
Company news

OneOme Named One of the World’s 50 Most Innovative Companies for 2018 by Fast Company

02/20/2018

MINNEAPOLIS (February 20, 2018) – OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications and enables healthcare providers to prescribe more effective medications, today announced that it is included in Fast Company’s annual ranking of the 50 Most Innovative Companies for 2018.

READ MORE

Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

01/10/2018

MINNEAPOLIS (January 10, 2018) – Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety.

READ MORE

OneOme Wins 2017 Tekne Award in Healthcare

11/16/2017

MINNEAPOLIS (November 16, 2017) – Last night, OneOme was awarded a Tekne Award in Healthcare at the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards. The Tekne Awards honor companies and individuals in Minnesota who have demonstrated superior technology innovation and leadership. OneOme’s RightMed® pharmacogenomic solution leads the way in personalized medicine by identifying how a patient's DNA and current medications may affect their response to medications.

READ MORE

Concierge Medicine Forum Features OneOme Expert on Pharmacogenomics

10/26/2017

MINNEAPOLIS (October 26, 2017) – The Concierge Medicine Forum held this week in Atlanta will feature an expert on pharmacogenomics from OneOme, a leading precision medicine company. Ryan Gregg, Ph.D, medical science liaison from OneOme, will present a session on pharmacogenomics on Friday, October 27, at 11:05 a.m. at the Forsyth Conference Center in Cumming, Georgia. Pharmacogenomics is an emerging field that identifies how a patient's unique DNA and current medications may affect their response to medications.

READ MORE

In Singapore, OneOme and Tucker Medical Partner to Improve Preventive Care and Oncology Treatments

10/11/2017

SINGAPORE, MINNEAPOLIS (October 11, 2017) – In Singapore, OneOme and Tucker Medical are working together to help improve preventive care and oncology treatments. OneOme is a leader in pharmacogenomic testing and Tucker Medical is a multi-specialty practice offering personalized medicine and care in medical oncology, gastroenterology, and family medicine.

READ MORE

OneOme Named Finalist for 2017 Tekne Awards

10/10/2017

MINNEAPOLIS (October 10, 2017) – Today, OneOme announced it has been named a finalist for the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards in the Healthcare category. The Tekne Awards honor Minnesota companies and individuals who have shown superior technology innovation and leadership. OneOme’s RightMed® pharmacogenomic solution identifies how a patient's DNA and current medications may affect their response to medications.

READ MORE

Investment opportunities

If you are interested in being a part of the future of precision medicine and would like to discuss investment opportunities with OneOme, please contact us at INVEST@ONEOME.COM.

People of OneOme

Leadership

  • John Black

    JOHN L. BLACK III, M.D. — CO-FOUNDER

    John L. Black III, M.D. is one of the co-founders of OneOme and also a consultant in the Division of Clinical Biochemistry and Immunology with a joint appointment in the Department of Psychiatry and Psychology at Mayo Clinic in Rochester. He joined the staff of Mayo Clinic in 1985 and is currently the co-director of the Personalized Genomics Laboratory. He received his B.A. and M.S. in psychology from the University of Wyoming. He received his M.D. (cum laude) from Creighton University School of Medicine. He is board certified in general, geriatric, and addiction psychiatry and is a clinical chemist.

  • Paul Owen

    PAUL OWEN — CHIEF EXECUTIVE OFFICER

    Paul joined OneOme as its President and COO in August 2015 and became CEO in June of 2016. Prior to OneOme, Paul led global commercialization for Invitae, a San Francisco-based hereditary disease diagnostics company that is listed on the New York Stock Exchange and that raised over $120Million in capital during Paul’s tenure. Prior to Invitae, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul received his B.S. in business administration from the University of Wisconsin – Stout.

  • Jason Ross

    Jason Ross — CHIEF TECHNOLOGY OFFICER

    Jason is the Chief Technology Officer with over 20 years of Healthcare Information Technology experience. Prior to joining OneOme, Jason held the position of IT Section Head at Mayo Clinic and was responsible for leading their IT strategy for genomics, informatics and advanced analytics. In addition, he was the Associate Director of IT for Mayo Clinic’s Center for Individualized Medicine. Jason holds a B.S. in molecular biology from University of Wisconsin – Eau Claire and a M.A. in Healthcare Administration from St. Mary’s University of Minnesota.

  • Mark Sylvester

    MARK SYLVESTER — CHIEF FINANCIAL OFFICER

    Mark is currently the Chief Financial Officer (CFO) for OneOme and Invenshure, LLC. Previously, Mark was the CFO at The Emily Program, where he oversaw accounting, finance, payroll, and financial analytics. During his tenure, Mark sat on the board of directors, was a member of the senior leadership team, structured a debt and equity recapitalization, and was instrumental in business development during a period of rapid growth. Mark received his J.D. from the University of St. Thomas School of Law and B.A. from Saint John’s University.

  • Brian Arendt

    BRIAN ARENDT — SENIOR DIRECTOR OF COMMERCIAL OPERATIONS

    Brian joined OneOme as the Director of Commercial Operations in October 2015. Previously, he held management roles in operations, analytics, and IT for a genetic information company, diagnostic reference laboratory, and an integrated health system. Brian has a B.S. in marketing from Winona State University and an M.B.A. from the University of Wisconsin — La Crosse.

  • Don Skifter

    DON SKIFTER — VICE PRESIDENT OF NORTH AMERICAN SALES AND BUSINESS DEVELOPMENT

    Don joined the OneOme team in May of 2016 as Director of East Sales and after making significant progress advancing OneOme's commercial efforts was subsequently promoted to Vice President of North American Sales and Business Development. Don has spent the past 15 years of his career in various commercial roles within genetic technology and services sectors including roles most recently at the Broad Institute where he helped launch Broad Genomic Services and at Complete Genomics, Sequenom, and Invitrogen/Life Technologies/Thermo Fisher prior to that. Don received his PhD in pharmacology and neuroscience from the University of Nebraska Medical Center and his MBA from the University of Nebraska Omaha.

  • Jason Sheard

    JASON SHEARD — SENIOR DIRECTOR OF PRODUCT DEVELOPMENT

    Jason is the Director of Product Development at OneOme. He is also the Director of Operations at Invenshure, LLC and is a technical leader with diverse product development experience, outstanding customer and engineering management skills, and a proven ability to build consensus and motivate teams to excel. Previously, he was the Vice President of Products for Logic PD, and before that he was Director of Electrical Engineering. Jason has a B.S. in physics from Bethel University and an M.S. in mechanical engineering from the University of Minnesota — Twin Cities.

  • Bronwyn Hartung

    BRONWYN HARTUNG, PhD — LABORATORY DIRECTOR

    Bronwyn is the founder of Phoenix Laboratory Consulting, based in Prospect, Kentucky. She has 15 years of experience in molecular genetics, with expertise in the design and validation of laboratory-developed tests, high-complexity clinical laboratory operations, quality systems, regulatory compliance, and medical device software. Her pharmacogenetics specialties include CYP450 haplotype and copy number analysis, data interpretation, and reporting. She earned her B.S. in Biology at Trinity University and her Ph.D. at Indiana University, followed by a postdoctoral fellowship in microbial pathology at the University of Iowa.

  • Ross Higgins

    ROSS HIGGINS — SENIOR DIRECTOR OF LABORATORY OPERATIONS

    Ross Higgins joined OneOme in early 2016 and holds responsibility for organizing and directing laboratory operations for the company. Most recently, Ross served in a dual business development and product management role for Douglas Scientific, where he was responsible for driving both product development and market expansion efforts. Ross also brings extensive experience in the clinical laboratory field, owing to several years managing the molecular genetics department at a large, CAP-accredited reference laboratory. Ross has a B.S. in Clinical Laboratory Sciences and an M.B.A. from Virginia Commonwealth University. He also maintains ASCP certification as a Medical Laboratory Scientist.

  • Mark Billmayer

    MARK BILLMAYER — SENIOR DIRECTOR OF PGX PROGRAM DEVELOPMENT

    Mark leads pharmacogenomics program development for OneOme, focusing on plan sponsors and PBMs. He has worked in many facets of healthcare including health plans, hospitals and clinics, PBMs, pharmacies, consulting and marketing firms, and technology startups. Most recently, Mark served as Director of Product Development within Specialty Pharmacy for OptumRx. Previously, with Intellogy Health Designs, he consulted on a wide variety of projects with US Oncology, Teradata, Fujitsu, McKesson/Relay Health, Rocky Mountain Cancer Centers and more. Mark received his B.S. in health and medical marketing from the University Wisconsin-Superior.

Board Members

  • Troy Kopischke

    TROY KOPISCHKE — CO-FOUNDER AND CHAIRMAN OF THE BOARD

    Troy is the co-founder and chairman of the board of OneOme. He is also a co-CEO, co-founder, and managing partner of Invenshure. Previously, he was the President and Chief Financial Officer at Steady State Imaging, where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. Troy holds a B.S. in electrical engineering from the University of Minnesota as well as a B.A. in physics and a B.A. in engineering science from Bethel College.

  • Harlan Langstraat

    HARLAN LANGSTRAAT, RPH

    Harlan serves as a member of OneOme’s board. His career has included Sr. Management positions in for-profit and not-for-profit healthcare organizations. Most recently, Harlan managed the outpatient pharmacies, specialty pharmacy and retail medical supply businesses at Mayo Clinic in Rochester MN. Previously, Harlan held Sr. level management positions at a number of start-up healthcare companies including Quantum Health Resources and Caremark. Harlan has a B.S. in Pharmacy from South Dakota State University.

  • Jeremy Friese

    JEREMY FRIESE, M.D.

    Jeremy is managing partner at Invenshure, an early-stage venture firm based in Minneapolis, and helped launch OneOme, for which he now serves as a director. He is an active investor and board member in the diagnostics and genomics arenas. Jeremy was an interventional radiologist at Mayo Clinic, where he also served as Associate Chair of the Department of Radiology and ran business development for Mayo Global Business Solutions. Jeremy earned his M.D. at Mayo Medical School and completed surgery and radiology training at Mayo Clinic and Harvard Medical School. He earned his M.B.A. from Harvard Business School.

  • Keith Stewart

    KEITH STEWART, PHD

    Dr. Keith Stewart is a consultant in the Division of Hematology and Oncology, Department of Internal Medicine at Mayo Clinic. He currently serves as the Carlson and Nelson Endowed Director of the Center for Individualized Medicine at Mayo Clinic and is recognized as the Vasek and Anna Maria Polak Professor of Cancer Research. His clinical practice and research focuses on genomics and individualized treatment of blood cancers such as multiple myeloma. Dr. Stewart earned his medical degree at Aberdeen University Medical School, United Kingdom, and an MBA degree at the University of Western Ontario.

Advisors

  • Justin Odegaard

    JUSTIN ODEGAARD — CLINICAL & MEDICAL ADVISOR

    Justin Odegaard joined OneOme in February 2016 as Laboratory Director. Prior to OneOme, Justin was the Director of Molecular Pathology at Lifecode and is also the Laboratory Director and Senior Medical Director at Guardant Health. Justin received his M.D. and Ph.D. from Stanford University, and trained at Stanford University Hospital in surgical and molecular pathology, where he remains as a part-time Instructor of Pathology.

  • Jill Davies

    JILL DAVIES — GENETIC COUNSELOR

    Jill Davies is Co-Founder and Chief Operating Officer for GeneMatters. Prior to joining GeneMatters in 2016, Jill was Director of Genetics at the Medcan Clinic in Toronto where she was responsible for developing and delivering leading-edge clinical genomics services. With over 15 years of experience in the genetic counseling field, Jill has broad expertise across clinical services, product development, business development and operations. She has a special interest in the role of genomics in primary care and preventive medicine as well as the use of technology to enable access to genomic information and services.

  • Liewei Wang

    LIEWEI WANG, M.D., Ph.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Wang is a professor in the Department of Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic Rochester. Her research involves the application of high-throughput "omics" technologies to identify biomarkers that might help us individualize cancer therapies, understand mechanisms of drug action, and facilitate target identification and drug development. She is also a co-leader of the Mayo Pharmacogenomics Program within the Mayo CIM, where many of the projects involving personalized medicine have been conducted. She is the co-PI for the Mayo-NIH clinical pharmacology T32 training grant and the Associate Director for the Mayo MPET graduate program.

  • Richard Weinshilboum

    RICHARD WEINSHILBOUM, M.D. — MAYO CLINIC, Co-founder OneOme

    Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in internal medicine at the Massachusetts General Hospital. He was also a pharmacology Research Associate at the National Institutes of Health (NIH). He began his affiliation with the Mayo Medical School and Mayo Clinic in 1972, where he is presently Professor of Pharmacology and Medicine and Mary Lou and John H. Dasburg Professor of Cancer Genomics Research. He currently directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine and is co-Principal Investigator of the long-standing US NIH Pharmacogenomics Research Network Center at the Mayo Clinic.

Team

Ben Metzger

Software Development

Ben
Metzger

Brett Miller

Inside Sales

Brett
Miller

Catie Pfeilsticker

Laboratory Operations

Catie
Pfeilsticker

Colin Pistulka

Commercial Operations

Colin
Pistulka

Colleen Owen

Human Resources

Colleen
Owen

Erica Schnettler

Medical Affairs

Erica
Schnettler

Erik Anderson

IT

Erik
Anderson

Erin Rech

Business Development

Erin
Rech

Grant Williams

Inside Sales

Grant
Williams

Hennessy McIlvaine

Clinical Development

Hennessy
McIlvaine

Jacob Sevlie

Software Development

Jacob
Sevlie

Jake Comstock

Business Development

Jake
Comstock

Jeff Driscoll

Business Development

Jeff
Driscoll

Jordan Gutzman

Inside Sales

Jordan
Gutzman

Kathleen Bosse

Clinical Development

Kathleen
Bosse

Katie Mittelstadt

Marketing

Katie
Mittelstadt

Kesah Schmitt

Marketing

Kesah
Schmitt

Kirsten Bauer

Laboratory Operations

Kirsten
Bauer

Kurt Wiersma

Software Development

Kurt
Wiersma

Lilly Drew

Commercial Operations

Lilly
Drew

Linda McDowell

Business Development

Linda
McDowell

Lydia Kantor

Marketing

Lydia
Kantor

Matt Hilden

Software Development

Matt
Hilden

Megan Adelman

Clinical Development

Megan
Adelman

Morgan Donaldson

Business Development

Morgan
Donaldson

Preston Anderson

Inside Sales

Preston
Anderson

Ryan Gregg

Medical Affairs

Ryan
Gregg

Sam Fortin

Marketing

Sam
Fortin

Steve Sheldon

IT

Steve
Sheldon

Tyler Koep

Medical Affairs

Tyler
Koep

Vaishnavi Soundararajan

Clinical Development

Vaishnavi
Soundararajan

Vince Catania

Business Development

Vince
Catania

Wrenda Teeple

Clinical Development

Wrenda
Teeple